May 20, 2019
Personalis Enters into a Research Agreement with FLX Bio to Provide Comprehensive Tumor Immunogenomic Profiling for Clinical Study
Cutting Edge Platform Enables the Detection of Changes in the Tumor Microenvironment Following Treatment with FLX475 MENLO PARK, Calif. &…